Selection and identification of single domain antibody fragments from camel heavy-chain antibodies, FEBS Letters, vol.15, issue.3, pp.521-526, 1997. ,
DOI : 10.1016/S0014-5793(97)01062-4
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease, Nature Medicine, vol.6, issue.8, pp.916-919, 2000. ,
DOI : 10.1038/78682
Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases, Mol. Med, vol.3, pp.695-707, 1997. ,
Amyloid ??-protein (A??) assembly: A??40 and A??42 oligomerize through distinct pathways, Proceedings of the National Academy of Sciences, vol.100, issue.1, pp.330-335, 2003. ,
DOI : 10.1073/pnas.222681699
Neuropathological stageing of Alzheimer-related changes, Acta Neuropathologica, vol.80, issue.4, pp.239-259, 1991. ,
DOI : 10.1007/BF00308809
Neutralizing Human Anti Crotoxin scFv Isolated from a Nonimmunized Phage Library, Scandinavian Journal of Immunology, vol.22, issue.4, pp.337-344, 2000. ,
DOI : 10.1111/j.1432-1033.1995.tb20355.x
Natural oligomers of the amyloid-?? protein specifically disrupt cognitive function, Nature Neuroscience, vol.62, issue.1, pp.79-84, 2005. ,
DOI : 10.1073/pnas.94.4.1550
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies, Proceedings of the National Academy of Sciences, vol.103, issue.12, pp.4586-4591, 2006. ,
DOI : 10.1073/pnas.0505379103
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease, Neurology, vol.59, issue.3, pp.398-407, 2002. ,
DOI : 10.1212/WNL.59.3.398
Three Camelid VHH Domains in Complex with Porcine Pancreatic alpha -Amylase. INHIBITION AND VERSATILITY OF BINDING TOPOLOGY, Journal of Biological Chemistry, vol.277, issue.26, pp.23645-23650, 2002. ,
DOI : 10.1074/jbc.M202327200
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme, Nature Structural Biology, vol.50, issue.9, pp.803-811, 1996. ,
DOI : 10.1107/S0021889891004399
Immunotherapy for Alzheimer's disease, The Lancet Neurology, vol.2, issue.4, pp.215-220, 2003. ,
DOI : 10.1016/S1474-4422(03)00349-1
Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay, Journal of Immunological Methods, vol.77, issue.2, pp.305-319, 1985. ,
DOI : 10.1016/0022-1759(85)90044-4
Amyloid Deposits and Amyloidosis, New England Journal of Medicine, vol.302, issue.23, pp.1283-1292, 1980. ,
DOI : 10.1056/NEJM198006053022305
Intraneuronal A??42 Accumulation in Human Brain, The American Journal of Pathology, vol.156, issue.1, pp.15-20, 2000. ,
DOI : 10.1016/S0002-9440(10)64700-1
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid ??-peptide, Nature Reviews Molecular Cell Biology, vol.26, issue.2, 2007. ,
DOI : 10.1038/nrm2101
Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing A protofibrils, Proc. Natl. Acad. Sci. U.S.A. 104, pp.19232-19237, 2007. ,
DOI : 10.1073/pnas.0703793104
Naturally occurring antibodies devoid of light chains, Nature, vol.363, issue.6428, pp.446-448, 1993. ,
DOI : 10.1038/363446a0
Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons, J. Neurosci, vol.19, pp.8876-8884, 1999. ,
Amyloid precursor protein processing and Abeta 42 deposition in a transgenic mouse model of Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 94, pp.1550-1555, 1997. ,
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis, Science, vol.300, issue.5618, pp.486-489, 2003. ,
DOI : 10.1126/science.1079469
Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains, J. Biol. Chem, vol.271, pp.4077-4081, 1996. ,
Synaptic Targeting by Alzheimer's-Related Amyloid ?? Oligomers, Journal of Neuroscience, vol.24, issue.45, pp.10191-10200, 2004. ,
DOI : 10.1523/JNEUROSCI.3432-04.2004
Similar binding properties for a neutralizing anti-tetanus toxoid human monoclonal antibody and its bacterially expressed Fab, Research in Immunology, vol.146, issue.6, pp.373-382, 1995. ,
DOI : 10.1016/0923-2494(96)81041-8
Monoclonal antibodies that target pathological assemblies of A??, Journal of Neurochemistry, vol.579, issue.Suppl 2, pp.23-35, 2007. ,
DOI : 10.1111/j.1471-4159.2006.04157.x
Enzyme immunoassay using monoclonal antibodies to study conformational changes of human serum albumin, Analytical Biochemistry, vol.174, issue.1, pp.308-312, 1988. ,
DOI : 10.1016/0003-2697(88)90550-7
Targeting Amyloid-beta Peptide (Abeta) Oligomers by Passive Immunization with a Conformation-selective Monoclonal Antibody Improves Learning and Memory in Abeta Precursor Protein (APP) Transgenic Mice, Journal of Biological Chemistry, vol.281, issue.7, pp.4292-4299, 2006. ,
DOI : 10.1074/jbc.M511018200
Effect of Different Anti-A?? Antibodies on A?? Fibrillogenesis as Assessed by Atomic Force Microscopy, Journal of Molecular Biology, vol.335, issue.4, pp.997-1006, 2004. ,
DOI : 10.1016/j.jmb.2003.11.019
Thioflavine T interaction with synthetic Alzheimer's disease ??-amyloid peptides: Detection of amyloid aggregation in solution, Protein Science, vol.8, issue.3, pp.404-410, 1993. ,
DOI : 10.1002/pro.5560020312
A??42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease, The Lancet, vol.355, issue.9197, pp.42-43, 2000. ,
DOI : 10.1016/S0140-6736(99)04937-5
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983. ,
DOI : 10.1016/0022-1759(83)90303-4
domain from naturally occurring camel heavy chain immunoglobulins lacking light chains, "Protein Engineering, Design and Selection", vol.7, issue.9, pp.1129-1135, 1994. ,
DOI : 10.1093/protein/7.9.1129
Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains, Trends in Biochemical Sciences, vol.26, issue.4, pp.230-235, 2001. ,
DOI : 10.1016/S0968-0004(01)01790-X
Anti-Aggregating Antibodies, a New Approach Towards Treatment of Conformational Diseases, Current Medicinal Chemistry, vol.9, issue.19, pp.1737-1749, 2002. ,
DOI : 10.2174/0929867023369141
Intraneuronal Alzheimer A??42 Accumulates in Multivesicular Bodies and Is Associated with Synaptic Pathology, The American Journal of Pathology, vol.161, issue.5, pp.1869-1878, 2002. ,
DOI : 10.1016/S0002-9440(10)64463-X
Effects of secreted oligomers of amyloid ??-protein on hippocampal synaptic plasticity: a potent role for trimers, The Journal of Physiology, vol.64, issue.2, pp.477-492, 2006. ,
DOI : 10.1113/jphysiol.2005.103754
Oligomers on the Brain: the Emerging Role of Soluble Protein Aggregates in Neurodegeneration., Protein & Peptide Letters, vol.11, issue.3, pp.213-228, 2004. ,
DOI : 10.2174/0929866043407174
Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration, Acta Neuropathol, 2007. ,
Aspects on human amyloid forms and their fibril polypeptides, FEBS Journal, vol.145, issue.23, pp.5942-5949, 2005. ,
DOI : 10.1111/j.1742-4658.2005.05024.x
Intraneuronal APP/A?? Trafficking and Plaque Formation in ??-Amyloid Precursor Protein and Presenilin-1 Transgenic Mice, Brain Pathology, vol.273, issue.3, pp.275-286, 2002. ,
DOI : 10.1111/j.1750-3639.2002.tb00442.x
Diffuse plaques associated with astroglial amyloid ?? protein, possibly showing a disappearing stage of senile plaques, Acta Neuropathologica, vol.95, issue.3, pp.217-222, 1998. ,
DOI : 10.1007/s004010050790
A??42 is More Rigid than A??40 at the C Terminus: Implications for A?? Aggregation and Toxicity, Journal of Molecular Biology, vol.364, issue.5, pp.853-862, 2006. ,
DOI : 10.1016/j.jmb.2006.09.046